Risk factors and prognosis of pulmonary embolism in patients with lung cancer.

Malignant tumors are often complicated with venous thrombosis and pulmonary embolism (PE), particularly in lung cancer. However, owing to the limited data regarding the clinical course about PE in lung cancer patients, the aim of this study is to analyze the risk factors and prognosis of patients with PE and lung cancer. We performed a retrospective case-control study, the clinical data of 90 patients in the First Affiliated Hospital of People's Liberation Army General Hospital between Jan 2010 and Jan 2015 were analyzed, including 30 lung cancer patients with PE (PE group), 60 lung cancer patients without PE (non-PE group), treated during the same period.

[Clinical characteristics of lung cancer complicated with pulmonary embolism].

Objective: To investigate the clinical characteristics, risk factors, and survival time of patients with lung cancer (LC) and pulmonary embolism (PE).

Methods: A total of 17 LC patients complicated with PE admitted to this hospital from February 2012 to January 2014 were retrospectively reviewed. There were 13 males and 4 females, with an average age of (65±9) years (range, 38-82 years).

Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.

Background: To evaluate the value of combined detection of serum carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), and carbohydrateantigen 125 (CA125) for the clinical diagnosis of non- small cell lung cancer (NSCLC).

Materials And Methods: Serum CEA, CYFRA21-1 and CA125 were assessed in 140 patients with NSCLC, 90 patients with benign lung disease and 90 normal control subjects, and differences of expression were compared in each group, and joint effects of these tumor markers in the diagnosis of NSCLC were analyzed.

Results: Serum CEA, CYFRA21-1 and CA125 in patients with NSCLC were significantly higher than those with benign lung disease and normal controls (P<0.

Multicentre investigation of pathogenic bacteria and antibiotic resistance genes in Chinese patients with acute exacerbation of chronic obstructive pulmonary disease.

Objective: A prospective observational study to investigate the distribution and antimicrobial resistance of pathogenic bacteria in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in Beijing, China.

Methods: Patients with AECOPD were recruited from 11 general hospitals. Sputum specimens were cultured and bacteria identified.

Intervention study of the association of antibiotic utilization measures with control of extended-spectrum beta-lactamase (ESBL)-producing bacteria.

We investigated the effects of replacing third-/fourth-generation cephalosporins with piperacillin-tazobactam on the rate of acquisition of extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli by patients hospitalized in a Department of Respiratory Medicine. This 9-month, prospective, non-controlled, intervention study comprised two phases: a 3-month pre-intervention phase (Phase I) and a 6-month intervention phase (Phase II), during which the use of third-/forth-generation cephalosporins was restricted and replaced by piperacillin-tazobactam. Rectal swabs were obtained within 24 h after admission (baseline screening), weekly, and 48 h before discharge during Phase I and the last 3 months of Phase II (Phase IIb).

[A case report of pulmonary actinomycosis and review of the literature].

Objective: To improve the awareness of primary pulmonary actinomycosis.

Method: One case of primary endobronchial actinomycosis was reported and 187 cases of primary pulmonary actinomycosis reported in the literature were reviewed.

Results: A 66-year-old female had had recurrent cough, sputum production and fever for 4 years.

[The value of serum tumor marker CA125 and CEA in the diagonosis of non-small cell lung cancer.].

Background: Tumor marker cancer antigen 125(CA125) and carcinoembryonic antigen (CEA) all are the tumor markers found early. It was reported that the positive rate of CEA was highly in adenocarcinoma, after being analyzed all the case reports of non-small cell lung cancer (NSCLC) in recent 3 years, it was found that positive rate of CA125 was much higher in NSCLC than that of literatures. So, it's necessary to evaluate the value of serum CA125 and CEA measurement for NSCLC.

Characteristics of and strategies for patients with severe burn-blast combined injury.

Background: Severe burn-blast combined injury is a great challenge to medical teams for its high mortality. The aim of this study was to elucidate the clinical characteristics of the injury and to present our clinical experiences on the treatment of such cases.

Methods: Five patients with severe burn-blast combined injuries were admitted to our hospital 77 hours post-injury on June 7, 2005.

[Misdiagnosis analysis of pulmonary lymphomatosis carcinomatous].

Background: Pulmonary lymphomatosis carcinomatous (PLC) is a special type of pulmonary metastasis of carcinoma. It is easy to be misdiagnosed as other pulmonary diseases. In this study the clinical manifestation of PLC is analyzed to improve the understanding of the clinical manifestations of PLC and to avoid or reduce misdiagnosis.